We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
-16.63%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$589M
AUM Growth
-$370M
Cap. Flow
-$220M
Cap. Flow %
-37.27%
Top 10 Hldgs %
49.75%
Holding
105
New
23
Increased
20
Reduced
14
Closed
36

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$18.6M
2
LNG icon
Cheniere Energy
LNG
+$16.1M
3
CNC icon
Centene
CNC
+$13.6M
4
ARMK icon
Aramark
ARMK
+$13M
5
OLN icon
Olin
OLN
+$8.18M

Top Sells

Rank Stock Value
1
XOP icon
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+$38.9M
2
AA icon
Alcoa
AA
+$33.1M
3
URI icon
United Rentals
URI
+$24.6M
4
TECK icon
Teck Resources
TECK
+$19.4M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$16.2M

Sector Composition

Rank Sector Weight
1 Healthcare 21.25%
2 Financials 9.87%
3 Consumer Discretionary 8.67%
4 Industrials 8.18%
5 Communication Services 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCYX icon
51
SCYNEXIS
SCYX
$51.6M
$2.41M 0.41%
162,131
+62,500
+63% +$1.2M
CG icon
52
Carlyle Group
CG
$17.6B
$2.38M 0.4%
+75,000
New +$2.87M
BX icon
53
Blackstone
BX
$107B
$2.28M 0.39%
+25,000
New +$2.7M
DIS icon
54
Walt Disney
DIS
$181B
$2.12M 0.36%
22,500
-7,500
-25% -$832K
TAP icon
55
Molson Coors Class B
TAP
$7.92B
$2.11M 0.36%
38,750
– –
SE icon
56
CALL
Sea Limited
SE
$68B
$2.01M 0.34%
+30,000
New +$2.56M
EUCR
57
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$1.98M 0.34%
200,000
– –
CRIS icon
58
Curis
CRIS
$8.59M
$1.9M 0.32%
4,811
+848
+21% +$354K
BBBY
59
Bed Bath & Beyond
BBBY
$429M
$1.88M 0.32%
82,500
+5,500
+7% +$165K
XAIR icon
60
CALL
Beyond Air
XAIR
$4.01M
$1.67M 0.28%
625
+375
+150% +$908K
TVRD
61
CALL
Tvardi Therapeutics
TVRD
$23.1M
$1.37M 0.23%
+4,167
New +$1.46M
GRFS
62
Grifois
GRFS
$5.33B
$1.34M 0.23%
+112,490
New +$1.34M
BBBY
63
CALL
Bed Bath & Beyond
BBBY
$429M
$1.25M 0.21%
+55,000
New +$1.65M
JSPR icon
64
Jasper Therapeutics
JSPR
$21.5M
$1.04M 0.18%
54,000
– –
NVNO
65
enVVeno Medical
NVNO
$6.78M
$829K 0.14%
6,262
– –
VINC
66
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$508K 0.09%
19,250
– –
MTEM
67
DELISTED
Molecular Templates, Inc.
MTEM
$481K 0.08%
35,207
-32,881
-48% -$769K
MSACW
68
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$6K ﹤0.01%
33,332
– –
EUCRW
69
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$2K ﹤0.01%
66,665
– –
AA icon
70
Alcoa
AA
$12.5B
– –
-368,200
Closed -$33.1M
ABT icon
71
Abbott
ABT
$187B
– –
-41,600
Closed -$4.92M
ACET icon
72
Adicet Bio
ACET
$74.2M
– –
-17,188
Closed -$5.49M
AMN icon
73
PUT
AMN Healthcare
AMN
$1.19B
– –
-100,000
Closed -$10.4M
APLS
74
PUT
DELISTED
Apellis Pharmaceuticals
APLS
– –
-150,000
Closed -$7.62M
AZEK
75
DELISTED
The AZEK Co
AZEK
– –
-518,000
Closed -$12.9M
1 2
3
4 5

Similar funds

GC
Greenvale Capital London, United Kingdom $912M AUM 34.2% 1-Year Est. Return
ICP
Ironvine Capital Partners Omaha, Nebraska $910M AUM 10.64% 1-Year Est. Return
SAA
Southeast Asset Advisors Thomasville, Georgia $913M AUM 25.32% 1-Year Est. Return
GIG
Goodnow Investment Group Darien, Connecticut $913M AUM 11.84% 1-Year Est. Return
SI
Symmetry Investments St Helier, Jersey $913M AUM 30.59% 1-Year Est. Return
PAMI
Perseverance Asset Management International George Town, Cayman Islands $909M AUM 17.42% 1-Year Est. Return
BDP
Brehaut David Pascal $908M AUM
DWP
Destiny Wealth Partners Tavares, Florida $914M AUM 18.14% 1-Year Est. Return

Kingdon Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Kingdon Capital Management held 105 positions worth $589M, down 39% from $959M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Kingdon Capital Management withdrew a net $220M in Q2 2022, closing 36 positions and reducing 14 holdings. Its most notable exit was State Street SPDR S&P Oil & Gas Exploration & Production ETF, an estimated $38.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Kingdon Capital Management opened a new position in Humana worth $19.6M.

  • Kingdon Capital Management's largest Q2 2022 buy was Humana: 41,900 shares worth $19.6M.
  • Kingdon Capital Management added most to Bloomin' Brands in Q2 2022, an estimated $7.04M increase.
  • Kingdon Capital Management's biggest Q2 2022 reduction was Teck Resources, cutting an estimated $19.4M.
  • Kingdon Capital Management fully exited State Street SPDR S&P Oil & Gas Exploration & Production ETF in Q2 2022, selling an estimated $38.9M.
  • Kingdon Capital Management's ten largest holdings make up 50% of its $589M portfolio in Q2 2022.
  • Kingdon Capital Management opened 23 new positions and closed 36 in Q2 2022.
  • Kingdon Capital Management's portfolio value fell 39% quarter-over-quarter to $589M.

Based on Kingdon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.